Follow the Senti Biosciences, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €10.6m. The latest transaction was filed on 11 March 2026 (Retenue fiscale). Among the most active insiders: Rajangam Kanya. The full history is free.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€20,568
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Senti Biosciences, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$13.50.
42Σ signal
Buys n/a€20,568 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Senti Biosciences, Inc. is a biotechnology company that develops gene and cell therapies. It focuses on using synthetic biology to address serious diseases.